[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT05934565":3,"trial-entities:NCT05934565":113,"trial-summary:NCT05934565":117},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":21,"study_type":25,"primary_purpose":26,"phases":27,"enrollment_info":29,"interventions":32,"primary_outcomes":37,"secondary_outcomes":42,"sex":72,"minimum_age":73,"maximum_age":74,"healthy_volunteers":75,"eligibility_criteria":76,"std_ages":87,"locations":90,"central_contacts":104,"overall_officials":110,"references":111,"see_also_links":112},"NCT05934565","R01AT012166-01A1","Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF","Mindful Steps: Coupling Technology and Mind-Body Exercise to Facilitate Physical Activity in Chronic Cardiopulmonary Disease","RECRUITING","2028-06-30","2025-05","2025-05-28","2025-04-28","Beth Israel Deaconess Medical Center","OTHER",true,"The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and\u002For HF. The main question it aims to answer is can this intervention promote physical activity as measured by daily step counts in sedentary patients with COPD and\u002For HF. Participants will be randomized (1:1 ratio) to receive either the Mindful Steps intervention or usual care for 12 months, with both arms receiving a Walking for Health education booklet.","This is a 2-arm parallel remotely delivered RCT. A total of 136 participants with COPD and\u002For HF will be randomized in a 1:1 ratio to one of 2 arms in a pragmatic design: 1) Mindful Steps multi-modal intervention, or 2) usual care (including an education booklet on walking). Subjects will participate in the intervention for 12 months. Testing will occur at baseline, 3, 6, 12 (end intervention), and 15 months (post-intervention follow up) for all participants. Physical activity as measured by pedometer (i.e., daily step counts) at 12 months is the primary outcome to assess the efficacy of the Mindful Steps intervention. Secondary outcomes include cognitive-behavioral measures that may relate to behavior change in a conceptual model (self-efficacy, intrinsic motivation, mindful awareness\u002Finteroception) as well as patient-centered clinical outcomes (HRQL, dyspnea, fatigue, PA engagement, sedentary behavior).",[19,20],"Chronic Obstructive Pulmonary Disease","Chronic Heart Failure",[22,23,24],"Mind-Body Exercise","FitBit","Mindful Steps","INTERVENTIONAL","TREATMENT",[28],"NA",{"count":30,"type":31},136,"ESTIMATED",[33],{"type":34,"name":24,"description":35,"armGroupLabels":36},"BEHAVIORAL","Integrated website, activity tracker, and mind-body training",[24],[38],{"measure":39,"description":40,"timeFrame":41},"Change in physical activity","Daily step counts will be measured as an objective proxy for physical activity using FitBit pedometers (FitBit Inspire 3)","baseline, months 3, 6, 12, and 15",[43,46,49,53,56,59,62,65,69],{"measure":44,"description":45,"timeFrame":41},"Change in self-efficacy","Exercise self-efficacy will be measured using the Self-Efficacy for Exercise Scale and the Self-Efficacy for Managing Chronic Disease Scale. The Self-Efficacy for Exercise Scale a 9-item validated scale; scores range from 9-28, with a higher score meaning more self-efficacy. The Self-Efficacy for Managing Chronic Disease Scale is a 6-item visual analog scale; scores range from 1-10, with a higher score indicating higher self-efficacy.",{"measure":47,"description":48,"timeFrame":41},"Change in intrinsic motivation","Intrinsic motivation will be measured using the Intrinsic Motivation Inventory. This is a 22-item scale validated with four sub-scales: interest\u002Fenjoyment, perceived competence, perceived choice, and pressure\u002Ftension. A higher score is better, with a scoring range of 22-154.",{"measure":50,"description":51,"timeFrame":52},"Qualitative inquiry","Half-hour semi-structured qualitative interviews guided by study staff will be conducted over video\u002Fphone in a random subset of 50 participants at the 6 and 12 month timepoints.","months 6 and 12",{"measure":54,"description":55,"timeFrame":41},"Change in disease-specific quality-of-life","Disease-specific quality-of-life will be measured using St. George's Respiratory Questionnaire (SGRQ) and The Minnesota Living with Heart Failure Questionnaire (MLFHQ). The SGRQ is a 50-item instrument developed and validated in COPD and calculates four scores: symptomatology, activity, impacts and an overall metric; scores range from 0-100, with higher scores indicating more limitations. The MLFHQ is a 21-item instrument; total scores range from 0-105, with higher scores indicating poorer quality-of-life.",{"measure":57,"description":58,"timeFrame":41},"Change in exercise engagement","Exercise engagement will be measured using the Community Healthy Activities Model Program for Seniors (CHAMPS) Physical Activity Questionnaire. This 41-item self-report questionnaire assesses engagement with physical activity, including frequency and duration, among older adults over the past 4 weeks. Separate scores are derived for physical activities of varying intensities. Frequency and estimated caloric expenditure are calculated per week for each of these physical activity categories, with higher scores indicating greater frequency and duration of exercise.",{"measure":60,"description":61,"timeFrame":41},"Change in sedentary behaviors\u002Ftime","Sedentary behaviors\u002Ftime will be measured using online weekly exercise logs. These online weekly exercise logs will be used to assess frequency and categorize exercises.",{"measure":63,"description":64,"timeFrame":41},"Change in dyspnea","Dyspnea is being measured using the UCSD Shortness of Breath Questionnaire - a 24 item questionnaire using a 6 point Likert scale; scores range from 0-120, with higher scores indicating greater dyspnea.",{"measure":66,"description":67,"timeFrame":68},"Change in fatigue","Fatigue will be measured using the The Patient-Reported Outcome Measurement Information System (PROMIS) Fatigue Short Form 7a. Raw scores range from 7-35, and each raw score is translated into a standardized T-score, with higher T-scores representing greater fatigue.","baseline, months 3, 6, 12 and 15",{"measure":70,"description":71,"timeFrame":68},"Change in mindful awareness","Mindful awareness will be measures using the Multidimensional Assessment of Interoceptive Awareness, consisting of 37 items (8 domains), each domain scored as the average score on a 6-point Likert.","ALL","40 Years",null,false,{"inclusion":77,"exclusion":81,"raw_text":86},[78,79,80],"Clinical diagnosis of COPD (defined as cigarette smoking history \\> 10 pack-years, and either a ratio of FEV1 to forced vital capacity \\\u003C 0.70 or chest CT evidence of emphysema) OR clinical diagnosis of HF syndrome (with left ventricular systolic dysfunction or preserved ejection fraction and New York Heart Association Class 1-3)","Medical clearance from provider to participate in an exercise program","Have an active email account; access to a computer device (desktop, laptop, tablet, or smartphone that supports the Fitbit app).",[82,83,84,85],"COPD or HF exacerbation in the previous month","Inability to ambulate","Inability to collect at least 7 of 14 days of baseline step counts","Current participation in a cardiac or pulmonary rehabilitation program","Inclusion Criteria:\n\n* Clinical diagnosis of COPD (defined as cigarette smoking history \\> 10 pack-years, and either a ratio of FEV1 to forced vital capacity \\\u003C 0.70 or chest CT evidence of emphysema) OR clinical diagnosis of HF syndrome (with left ventricular systolic dysfunction or preserved ejection fraction and New York Heart Association Class 1-3)\n* Medical clearance from provider to participate in an exercise program\n* Have an active email account; access to a computer device (desktop, laptop, tablet, or smartphone that supports the Fitbit app).\n\nExclusion Criteria:\n\n* COPD or HF exacerbation in the previous month\n* Inability to ambulate\n* Inability to collect at least 7 of 14 days of baseline step counts\n* Current participation in a cardiac or pulmonary rehabilitation program",[88,89],"ADULT","OLDER_ADULT",[91,100],{"facility":92,"status":8,"city":93,"state":94,"zip":95,"country":96,"geoPoint":97},"VA Boston","Boston","Massachusetts","02132","United States",{"lat":98,"lon":99},42.35843,-71.05977,{"facility":101,"status":8,"city":93,"state":94,"zip":102,"country":96,"geoPoint":103},"BIDMC","02215",{"lat":98,"lon":99},[105],{"name":106,"role":107,"phone":108,"email":109},"Gloria Yeh","CONTACT","(617) 667-2845","gyeh@bidmc.harvard.edu",[],[],[],{"nct_id":4,"conditions":114,"biomarkers":116},[115,19],"Chronic heart failure",[],{"nct_id":4,"found":15,"summary":118,"prompt_version":128},{"design":119,"status":120,"heading":121,"summary":122,"follow_up":123,"word_count":124,"commitments":125,"compensation":126,"drugs_mentioned":127},"This is a randomized controlled trial, meaning participants will be randomly assigned to either receive the Mindful Steps 2.0 program or usual care. There will be 136 participants in total.","completed","Mindful Steps 2.0 for Physical Activity in COPD and Heart Failure","This study is testing a program called Mindful Steps 2.0 to see if it helps people with Chronic Obstructive Pulmonary Disease (COPD) and\u002For Heart Failure (HF) become more physically active. Mindful Steps 2.0 includes a website, an activity tracker, and mind-body training. You could join if you are at least 40 years old, have a diagnosis of COPD or HF, and your doctor says you are medically cleared. The study aims to find out if Mindful Steps 2.0 can increase daily step counts compared to usual care. The study is currently unclear about its recruitment status and plans to enroll 136 participants.","You will be followed for 3 months after the 12-month intervention period, with a final assessment at 15 months.",102,"You would participate in the intervention for 12 months. Testing will occur at the beginning, and at 3, 6, 12, and 15 months.","Not stated in the trial record.",[24],"v2"]